Targeting the pVHL/HIF pathway in an effective way was proposed as a treatment option in renal cell carcinoma [35] but quantitative and qualitative differences among HIF-α subunits in this malignancy need to be considered [22]. This evidence concerns the gene VHL and renal cell carcinoma.